Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
In another win for rare disease, Travere nabs FDA’s first FSGS nod
Filspari in FSGS joins Denali’s Hunter syndrome drug Avlayah and Rocket’s gene therapy Kresladi among recent positive FDA decisions in rare disease.
Angus Liu
Apr 13, 2026 6:25pm
Pfizer rebuked by FDA for misleading Adcetris ads on Facebook
Apr 14, 2026 4:22am
Regulatory tracker: FDA approves generics for AZ's Farxiga
Apr 13, 2026 10:45am
Lilly touts Jaypirca fixed-duration win in ‘ambitious’ CLL trial
Apr 13, 2026 10:16am
Fierce Biotech
Regeneron rides into radiopharma via $2.1B biobucks Telix pact
Apr 13, 2026 7:24am
HHS updates ACIP charter with new emphasis on vaccine safety
Apr 10, 2026 4:06pm
More News
Fierce Biotech
Replimune to lay off staff after 'disappointing' second rejection
Apr 10, 2026 1:56pm
Sourcing bottlenecks increase US drug shortage risks: report
Apr 10, 2026 11:09am
Novartis to cut 114 more jobs at New Jersey HQ
Apr 10, 2026 10:52am
The top 10 pharma R&D budgets of 2025
Apr 10, 2026 9:28am
